The Air Force’s mystery space plane is back on Earth, following a record-breaking two-year mission.
The X-37B landed at NASA’s Kennedy Space Center in Florida early Sunday. The Air Force is mum about what the plane did in orbit after launching aboard a SpaceX rocket in 2017. The 780-day mission sets a new endurance record for the reusable test vehicle.
It looks like a space shuttle but is one-fourth the size at 29 feet.
Officials say this latest mission successfully completed its objectives. Experiments from the Air Force Research Laboratory were aboard.
This was the fifth spaceflight by a vehicle of this sort. No. 6 is planned next year with another launch from Cape Canaveral. According to Air Force Secretary Barbara Barrett, “Each successive mission advances our nation’s space capabilities.” (VOA)
Heart Rate gets altered in space but return to normal within 10 days on Earth, say researchers who examined cell-level cardiac function and gene expression in human heart cells cultured aboard the International Space Station (ISS) for 5.5 weeks.
Exposure to microgravity altered the expression of thousands of genes, but largely normal patterns of gene expression reappeared within 10 days after returning to Earth, according to the study published in the journal Stem Cell Reports.
“We’re surprised about how quickly human heart muscle cells are able to adapt to the environment in which they are placed, including microgravity,” said senior study author Joseph C. Wu from Stanford University.
These studies may provide insight into cellular mechanisms that could benefit astronaut health during long-duration spaceflight, or potentially lay the foundation for new insights into improving heart health on Earth.
Past studies have shown that spaceflight induces physiological changes in cardiac function, including reduced heart rate, lowered arterial pressure, and increased cardiac output.
But to date, most cardiovascular microgravity physiology studies have been conducted either in non-human models or at tissue, organ, or systemic levels.
Relatively little is known about the role of microgravity in influencing human cardiac function at the cellular level.
To address this question, the research team studied human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). They generated hiPSC lines from three individuals by reprogramming blood cells, and then differentiated them into heart cells.
Beating heart cells were then sent to the ISS aboard a SpaceX spacecraft as part of a commercial resupply service mission.
Simultaneously, ground control heart cells were cultured on Earth for comparison purposes.
Upon return to Earth, space-flown heart cells showed normal structure and morphology. However, they did adapt by modifying their beating pattern and calcium recycling patterns.
In addition, the researchers performed RNA sequencing of heart cells harvested at 4.5 weeks aboard the ISS, and 10 days after returning to Earth.
These results showed that 2,635 genes were differentially expressed among flight, post-flight, and ground control samples.
Most notably, gene pathways related to mitochondrial function were expressed more in space-flown heart cells.
A comparison of the samples revealed that heart cells adopt a unique gene expression pattern during spaceflight, which reverts to one that is similar to groundside controls upon return to normal gravity, the study noted.
According to Wu, limitations of the study include its short duration and the use of 2D cell culture.
In future studies, the researchers plan to examine the effects of spaceflight and microgravity using more physiologically relevant hiPSC-derived 3D heart tissues with various cell types, including blood vessel cells.